MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jstrokecerebrovasdis.2023.107407

Медицинская библиотека · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2023

Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke.

Low Chen Ee, Teo Yao Neng, Teo Yao Hao, Lim Isis Claire Zy, Rana Sounak, Lee Yong Qin, Chen Xintong, Fang Jun Tao, Lam Hsin Hui, Ong Kathleen, Yang Joanna, Kuntjoro Ivandito, Low Ting Ting, Lee Edward Cy, Sharma Vijay K, Yeo Leonard Ll, Sia Ching Hui, Tan Benjamin Yq, Lim Yinghao

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Patent foramen ovale (PFO) occurs in 25% of the general population and in 40% of cryptogenic ischemic stroke patients. Recent trials support PFO closure in selected patients with cryptogenic stroke. We examined the outcomes of transcatheter PFO closure in a real-world study cohort with cryptogenic stroke.

METHODS

Consecutive ischemic stroke patients who were classified as cryptogenic on the TOAST aetiology and diagnosed with a PFO were included. All patients underwent either transcatheter PFO closure or medical therapy. A 2:1 propensity score matching by sex and Risk-of-Paradoxical-Embolism (RoPE) score was performed. Multivariable regression models adjusted for sex and RoPE score.

RESULTS

Our cohort comprised 232 patients with mean age 44.3 years (SD 10.8) and median follow-up 1486.5 days. 33.2% were female. PFO closure (n=84) and medical therapy (n=148) groups were well-matched with <10% mean-difference in sex and RoPE score. Two patients in the treated group (2.4%) and seven in the control group (4.7%) had a recurrent ischemic stroke event. Multivariable Cox regression demonstrated a hazard-ratio of 0.26 (95%CI 0.03-2.13, P=0.21) for PFO closure compared to control. The incidence of atrial fibrillation (AF) detected post-PFO closure was similar between the treated and control (1.19% vs 1.35%, multivariable logistic regression odds-ratio 0.90, 95%CI 0.04-9.81, P=0.94). There were no major periprocedural complications documented. The difference in restricted mean survival-time free from stroke at two years between treated and control was 26.2 days (95%CI 5.52-46.85, P=0.013).

CONCLUSIONS

In this Asian cohort, we report a low incidence of ischemic stroke recurrence and new-onset AF in patients who underwent PFO closure. When compared to the medical therapy group, there was no significant difference in the incidence of stroke recurrence and new-onset AF. Further studies involving larger real-world cohorts are warranted to identify patients who are more likely to benefit from PFO closure.

Для цитирования: Low Chen Ee, Teo Yao Neng, Teo Yao Hao, Lim Isis Claire Zy, Rana Sounak, Lee Yong Qin, Chen Xintong, Fang Jun Tao, Lam Hsin Hui, Ong Kathleen, Yang Joanna, Kuntjoro Ivandito, Low Ting Ting, Lee Edward Cy, Sharma Vijay K, Yeo Leonard Ll, Sia Ching Hui, Tan Benjamin Yq, Lim Yinghao. Propensity-score matched analysis of patent foramen ovale closure in real-world study cohort with cryptogenic ischemic stroke.. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2023. DOI: 10.1016/j.jstrokecerebrovasdis.2023.107407.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.